Astellas Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Astellas company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Astellas Company Today - Breaking & Trending Today

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

- Leverages Poseida s proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors -
TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ Astellas. ....

Xyphos Biosciences , Astellas Pharma , Kristin Yarema , Naoki Okamura , Adam Pearson , Astellas Company , Poseida Therapeutics Inc , Exchange Commission , Xyphos Biosciences Inc , Areas Of Interest Astellas Pharma Inc , Astellas Pharma Inc , Poseida Therapeutics , Chimeric Antigen Receptor , Chief Strategy Officer , Primary Focus , Focus Area Approach , South San Francisco , Site Specific Gene Editing System , Booster Molecule , Looking Statements , Private Securities Litigation Reform Act ,

Opthea : Quarterly Activity Report - Form 6-K

Quarterly Activity Report

Q3 FY24

Highlights

•

Completion of enrolment in first trial of sozinibercept s Phase 3 pivotal program. ....

United States , Julie Clark , Xand Linkedin , Arshad Khanani , Silvana Guerci Lena , Arshadm Khanani , Fred Guerard , Astellas Company , Genentech United States Inc , Fellowship At Sierra Eye Associates , Exchange Commission , Leadership Team , University Of Nevada , Clinical Development , Drug Administration , Lomb Corporation , Reno School Of Medicine , Exchange Commission On , Sierra Eye Associates , Development Funding Agreement , Clinical Research , Roche Group , Regulatory Affairs , Alcon Inc , Opthea Limited , Quarterly Activity Report ,

Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy

Permanent J-code J2782 effective April 1, 2024
NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ Iveric Bio, An Astellas Company , today announced the U.S. Centers for Medicare and Medicaid Services. ....

Naoki Okamura , Michael Petroutsas , Iveric Bio , Medicaid Services , Astellas Pharma Inc , Astellas Company , Astellas Pharma Us Inc , Us Centers For Medicare , Healthcare Common Procedure Coding System , Focus Area Approach ,

Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor

Global retina expert joins to support sozinibercept development and launch preparationMELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) Opthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor. An internationally recognized retina specialist and clinical scientist, Dr. Khanani i ....

University Of Nevada , United States , Frederic Guerard , Arshadm Khanani , Rudi Michelson , Macula Society , Opthea Limited , Reno School Of Medicine , Monsoon Communications , American Society Of Retina Specialists , Fellowship At Sierra Eye Associates , Exchange Commission , Wilmer Eye Institute At Johns Hopkins University , Clinical Research , Astellas Company , Sierra Eye Associates , Retina Society , Investment In Biotechnology Companies , Company Media Enquiries , Chief Medical , Managing Partner , Clinical Associate Professor , Reno School , Chief Medical Advisor , Chief Executive Officer , Clinical Trials ,

Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor - Opthea (NASDAQ:OPT)

MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) Opthea Limited ((ASX:OPT, NASDAQ:OPT, "Opthea")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive ....

United States , University Of Nevada , Arshadm Khanani , Frederic Guerard , Rudi Michelson , Clinical Research , Opthea Limited , Retina Society , Exchange Commission , Monsoon Communications , Macula Society , Astellas Company , Reno School Of Medicine , Sierra Eye Associates , Wilmer Eye Institute At Johns Hopkins University , American Society Of Retina Specialists , Investment In Biotechnology Companies , Company Media Enquiries , Fellowship At Sierra Eye Associates , Chief Medical , Managing Partner , Clinical Associate Professor , Reno School , Chief Medical Advisor , Chief Executive Officer , Clinical Trials ,